Researchers developed an electrochemical biosensor and AI system that accurately detects lung cancer from breath samples.
Key Details
- 1University of Texas at Dallas and UT Southwestern developed an electrochemical biosensor for breath analysis.
- 2The technology uses AI to analyze eight volatile organic compounds linked to thoracic cancers.
- 3In a study with 67 patients (30 biopsy-confirmed cancers), the device identified cancer-linked VOCs with 90% accuracy.
- 4The approach is designed for early, noninvasive, and affordable screening of lung and esophageal cancers.
- 5The technology was reported in the August issue of Sensing and Bio-Sensing Research.
Why It Matters
This innovation could enable routine, noninvasive, and cost-effective early detection of lung and other thoracic cancers, potentially improving survival rates and reducing burdens on healthcare systems. The integration of machine learning in biosensing highlights the expanding role of AI in clinical cancer diagnostics.
Source
EurekAlert
Related News
•EurekAlert
AI Repurposes Routine CT Scans for Osteoporosis Detection
AI algorithms can extract bone density data from routine CT scans to identify osteoporosis, enabling opportunistic screening.
•EurekAlert
AI Outperforms Radiologists in Detecting Hidden Airway Objects on Chest CT
Southampton researchers developed an AI that surpassed radiologists in detecting hard-to-see airway obstructions on chest CT scans.
•EurekAlert
Zero-Cost EHR-Based AI Tool Scales Dementia Detection in Primary Care
A zero-cost, EHR-integrated AI tool significantly boosts dementia detection in primary care clinics without adding clinician workload.